| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.075 | 0.1 |